Ying Chen

6PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
Low-Dose Paclitaxel Combined with Dehydrocavidine Synergistically Suppresses Cervical Cancer by Inhibiting FASN/SCD1-Mediated Lipid Metabolism.

|Jan 30, 2026
Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence.

Zhiyan Zhou, Jin Li, Xingji Zhao

|Jul 18, 2024
Quantitative Proteomics Reveal the Mechanism of MiR-138-5p Suppressing Cervical Cancer via Targeting ZNF385A.

Qihang Peng, Yiting Deng, Guopan Li

|Dec 09, 2023
Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker.

Qian Wu, Pei Wang, Qihang Peng

|Mar 29, 2023
FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis.

Qian Wu, Jin Li, Pei Wang

|Feb 25, 2023
ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma.

Qihang Peng, Jin Li, Qian Wu

Pageof 1

Frequent Collaborators

5 joint publications

Jin Li

4 joint publications

Feng Ge

1 joint publications

Dehong Yan